NASDAQ:RVPH

Reviva Pharmaceuticals Holdings Stock Insider Trading

Healthcare > Biotechnology

Buy RVPH

*Your capital is at risk

$0.595

-0.0050 (-0.83%)

At Close: Jun 02, 2026

Reviva Pharmaceuticals Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 18.55M and sold 1.08M RVPH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	18.55M shares
● Sell	1.08M shares
98% Buy Activity Weak Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 10, 2022 Buy	Stock Option (right to buy) A-Award	Margolin Richard A Director	Director	3 900 Value: $0
Nov 10, 2022 Buy	Stock Option (right to buy) A-Award	Saxena Parag Director	Director	3 900 Value: $0
Nov 10, 2022 Buy	Stock Option (right to buy) A-Award	Patel Purav Director	Director	3 900 Value: $0
Sep 30, 2022 Buy	Common Stock, par value $0.0001 per share P-Purchase	Narayan Prabhu Chief Financial Officer	C-Suite Officer	50 000 Value: $83.0K
Sep 30, 2022 Buy	Common Stock, par value $0.0001 per share P-Purchase	Narayan Prabhu Chief Financial Officer	C-Suite Officer	50 000 Value: $83.0K
Sep 08, 2022 Buy	Common Stock Warrant (right to buy) P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	869 565 Value: $2.09M
Sep 08, 2022 Buy	Pre-Funded Warrant P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	869 565 Value: $87
Sep 08, 2022 Buy	Pre-Funded Warrant P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	513 834 Value: $51
Sep 08, 2022 Buy	Common Stock Warrant (right to buy) P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	513 834 Value: $1.23M
Sep 08, 2022 Buy	Common Stock Warrant (right to buy) P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	513 834 Value: $1.23M
Sep 08, 2022 Buy	Pre-Funded Warrant P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	513 834 Value: $51
Sep 08, 2022 Buy	Pre-Funded Warrant P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	869 565 Value: $87
Sep 08, 2022 Buy	Common Stock Warrant (right to buy) P-Purchase	Vedanta Partners, Llc 10 Percent Owner	10% Owner	869 565 Value: $2.09M
Jun 30, 2022 Buy	Common Stock, par value $0.0001 per share P-Purchase	Narayan Prabhu Chief Financial Officer	C-Suite Officer	50 000 Value: $60.7K
Jun 30, 2022 Buy	Common Stock, par value $0.0001 per share P-Purchase	Narayan Prabhu Chief Financial Officer	C-Suite Officer	50 000 Value: $60.7K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Margolin Richard A Director	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Funtleyder Leslie D. Director	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Patel Purav Director	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Saxena Parag	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Saxena Parag	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Patel Purav Director	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Margolin Richard A Director	Director	5 300 Value: $20.0K
Dec 08, 2021 Buy	Stock Option (right to buy) A-Award	Funtleyder Leslie D. Director	Director	5 300 Value: $20.0K
Jun 15, 2021 Buy	Stock Option (right to buy) A-Award	Funtleyder Leslie D. Director	Director	4 000 Value: $18.9K
Jun 15, 2021 Buy	Stock Option (right to buy) A-Award	Margolin Richard A Director	Director	4 000 Value: $18.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase...

Read Full Profile Here